Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dorsiflex
1. 70-07-5
2. Dorsiflex
3. Metoxadone
4. Methoxadone
5. 5-((2-methoxyphenoxy)methyl)oxazolidin-2-one
6. Mefenoxalone
7. Lenetranat
8. Mefenoxalona
9. Methoxydone
10. Moderamin
11. Trepidone
12. Xerene
13. Dorsilon
14. Lenetran
15. Placidex
16. Transpoise
17. Ekilan
18. Riself
19. Valanas
20. Lenetran Tab
21. Control-om
22. Alkapol Peg-400
23. 5-(o-methoxyphenoxymethyl)-2-oxazolidinone
24. Ahr 233
25. 5-(o-methoxyphenoxymethyl)-2-oxazolidone
26. Cl 27,319
27. Om-518
28. Cz87t54w8w
29. Methoxydon
30. 5-[(2-methoxyphenoxy)methyl]-2-oxazolidinone
31. Ahr-233
32. 2-oxazolidinone, 5-[(2-methoxyphenoxy)methyl]-
33. 5-[(2-methoxyphenoxy)methyl]-1,3-oxazolidin-2-one
34. Mephenoxalone (inn)
35. Ncgc00182072-02
36. Dsstox_cid_3255
37. Methoxydon(e)
38. Mephenoxalone [inn]
39. 2-oxazolidinone, 5-((o-methoxyphenoxy)methyl)-
40. Dsstox_rid_76943
41. Dsstox_gsid_23255
42. Mephenoxalonum
43. Metoxadon
44. Mephenoxalone [inn:dcf]
45. Cas-70-07-5
46. Mefenoxalona [inn-spanish]
47. Mephenoxalonum [inn-latin]
48. 2-oxazolidinone, 5-[(o-methoxyphenoxy)methyl]-
49. Einecs 200-723-3
50. Om 518
51. 5-((2-methoxyphenoxy)methyl)-2-oxazolidinone
52. Brn 0530698
53. Unii-cz87t54w8w
54. Tranpoise
55. Valans
56. Dorsiflex (tn)
57. Mephenoxalone [mi]
58. Schembl5392
59. Mephenoxalone Trepidone
60. Mephenoxalone [mart.]
61. Mephenoxalone [who-dd]
62. Chembl2104790
63. Dtxsid9023255
64. Chebi:134916
65. Tox21_113149
66. Akos016010058
67. Tox21_113149_1
68. Db13754
69. Ncgc00182072-03
70. 5-[(o-methoxyphenoxy)methyl]-2-oxazolidone
71. Ft-0671011
72. 5-[(o-methoxyphenoxy)methyl]-2-oxazolidinone
73. D07318
74. 070m075
75. 5-(2-methoxyphenoxymethyl)-1,3-oxazolidin-2-one
76. A923493
77. Q719694
78. 5-[(2-methoxyphenoxy) Methyl]-1,3-oxazolidin-2-one
79. 5-[(2-methoxyphenoxy)methyl]-1,3-oxazolidin-2-one #
80. 5-({[2-(methyloxy)phenyl]oxy}methyl)-1,3-oxazolidin-2-one
81. 5-[(2-methoxyphenoxy)methyl]-1,3-oxazolidin-2-one, Aldrichcpr
| Molecular Weight | 223.22 g/mol |
|---|---|
| Molecular Formula | C11H13NO4 |
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 223.08445790 g/mol |
| Monoisotopic Mass | 223.08445790 g/mol |
| Topological Polar Surface Area | 56.8 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 246 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
N - Nervous system
N05 - Psycholeptics
N05B - Anxiolytics
N05BX - Other anxiolytics
N05BX01 - Mephenoxalone
Market Place
ABOUT THIS PAGE
A Mephenoxalone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mephenoxalone, including repackagers and relabelers. The FDA regulates Mephenoxalone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mephenoxalone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mephenoxalone supplier is an individual or a company that provides Mephenoxalone active pharmaceutical ingredient (API) or Mephenoxalone finished formulations upon request. The Mephenoxalone suppliers may include Mephenoxalone API manufacturers, exporters, distributors and traders.
click here to find a list of Mephenoxalone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mephenoxalone DMF (Drug Master File) is a document detailing the whole manufacturing process of Mephenoxalone active pharmaceutical ingredient (API) in detail. Different forms of Mephenoxalone DMFs exist exist since differing nations have different regulations, such as Mephenoxalone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mephenoxalone DMF submitted to regulatory agencies in the US is known as a USDMF. Mephenoxalone USDMF includes data on Mephenoxalone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mephenoxalone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mephenoxalone suppliers with USDMF on PharmaCompass.
Mephenoxalone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mephenoxalone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mephenoxalone GMP manufacturer or Mephenoxalone GMP API supplier for your needs.
A Mephenoxalone CoA (Certificate of Analysis) is a formal document that attests to Mephenoxalone's compliance with Mephenoxalone specifications and serves as a tool for batch-level quality control.
Mephenoxalone CoA mostly includes findings from lab analyses of a specific batch. For each Mephenoxalone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mephenoxalone may be tested according to a variety of international standards, such as European Pharmacopoeia (Mephenoxalone EP), Mephenoxalone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mephenoxalone USP).
LOOKING FOR A SUPPLIER?
